119 related articles for article (PubMed ID: 2510163)
1. Coagulation factor XII (Hageman factor) Washington D.C.: inactive factor XIIa results from Cys-571----Ser substitution.
Miyata T; Kawabata S; Iwanaga S; Takahashi I; Alving B; Saito H
Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8319-22. PubMed ID: 2510163
[TBL] [Abstract][Full Text] [Related]
2. Activation of bovine factor VII (proconvertin) by factor XIIa (activated Hageman factor).
Kisiel W; Fujikawa K; Davie EW
Biochemistry; 1977 Sep; 16(19):4189-94. PubMed ID: 901769
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa.
Cool DE; Edgell CJ; Louie GV; Zoller MJ; Brayer GD; MacGillivray RT
J Biol Chem; 1985 Nov; 260(25):13666-76. PubMed ID: 3877053
[TBL] [Abstract][Full Text] [Related]
4. Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor).
McMullen BA; Fujikawa K
J Biol Chem; 1985 May; 260(9):5328-41. PubMed ID: 3886654
[TBL] [Abstract][Full Text] [Related]
5. Coagulation factor XII Locarno: the functional defect is caused by the amino acid substitution Arg 353-->Pro leading to loss of a kallikrein cleavage site.
Hovinga JK; Schaller J; Stricker H; Wuillemin WA; Furlan M; Lämmle B
Blood; 1994 Aug; 84(4):1173-81. PubMed ID: 8049433
[TBL] [Abstract][Full Text] [Related]
6. Characterization of bovine factor XIIa (activated Hageman factor).
Fujikawa K; Kurachi K; Davie EW
Biochemistry; 1977 Sep; 16(19):4182-8. PubMed ID: 901768
[TBL] [Abstract][Full Text] [Related]
7. Isolation and properties of an abnormal Hageman factor (Factor XII) molecule in a cross-reacting material-positive hageman trait plasma.
Saito H; Scialla SJ
J Clin Invest; 1981 Oct; 68(4):1028-35. PubMed ID: 6793628
[TBL] [Abstract][Full Text] [Related]
8. A new protein inhibitor of trypsin and activated Hageman factor from pumpkin (Cucurbita maxima) seeds.
Krishnamoorthi R; Gong YX; Richardson M
FEBS Lett; 1990 Oct; 273(1-2):163-7. PubMed ID: 2226848
[TBL] [Abstract][Full Text] [Related]
9. Difference between human and guinea pig Hageman factors in activation by bacterial proteinases: cleavage site shift due to local amino acid substitutions may determine the activation efficiency of serine proteinase zymogens.
Semba U; Shibuya Y; Tanase S; Nishino N; Makinose Y; Kambara T; Okabe H; Yamamoto T
Biochim Biophys Acta; 1993 Jan; 1180(3):267-76. PubMed ID: 8422433
[TBL] [Abstract][Full Text] [Related]
10. Amino acid sequence of human beta-factor XIIa.
Fujikawa K; McMullen BA
J Biol Chem; 1983 Sep; 258(18):10924-33. PubMed ID: 6604055
[TBL] [Abstract][Full Text] [Related]
11. Structure-function relationships for the IL-2 receptor system. V. Structure-activity analysis of modified and truncated forms of the Tac receptor protein: site-specific mutagenesis of cysteine residues.
Rusk CM; Neeper MP; Kuo LM; Kutny RM; Robb RJ
J Immunol; 1988 Apr; 140(7):2249-59. PubMed ID: 2832473
[TBL] [Abstract][Full Text] [Related]
12. Amino acid sequence and secondary structural analysis of the corn inhibitor of trypsin and activated Hageman Factor.
Mahoney WC; Hermodson MA; Jones B; Powers DD; Corfman RS; Reeck GR
J Biol Chem; 1984 Jul; 259(13):8412-6. PubMed ID: 6610678
[TBL] [Abstract][Full Text] [Related]
13. Primary structure of guinea-pig Hageman factor: sequence around the cleavage site differs from the human molecule.
Semba U; Yamamoto T; Kunisada T; Shibuya Y; Tanase S; Kambara T; Okabe H
Biochim Biophys Acta; 1992 Sep; 1159(2):113-21. PubMed ID: 1390917
[TBL] [Abstract][Full Text] [Related]
14. Interaction of trypsin, beta-factor XIIa, and plasma kallikrein with a trypsin inhibitor isolated from barley seeds: a comparison with the corn inhibitor of activated Hageman factor.
Chong GL; Reeck GR
Thromb Res; 1987 Oct; 48(2):211-21. PubMed ID: 3501175
[TBL] [Abstract][Full Text] [Related]
15. Human Hageman factor and its fragments.
Silverberg M; Kaplan AP
Methods Enzymol; 1988; 163():68-80. PubMed ID: 3237092
[No Abstract] [Full Text] [Related]
16. Plasminogen Tochigi: inactive plasmin resulting from replacement of alanine-600 by threonine in the active site.
Miyata T; Iwanaga S; Sakata Y; Aoki N
Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6132-6. PubMed ID: 6216475
[TBL] [Abstract][Full Text] [Related]
17. Partial identification of the Zn2+-binding sites in factor XII and its activation derivatives.
Røjkaer R; Schousboe I
Eur J Biochem; 1997 Jul; 247(2):491-6. PubMed ID: 9266689
[TBL] [Abstract][Full Text] [Related]
18. O-linked fucose is present in the first epidermal growth factor domain of factor XII but not protein C.
Harris RJ; Ling VT; Spellman MW
J Biol Chem; 1992 Mar; 267(8):5102-7. PubMed ID: 1544894
[TBL] [Abstract][Full Text] [Related]
19. Factor XII: Hageman factor.
Pixley RA; Colman RW
Methods Enzymol; 1993; 222():51-65. PubMed ID: 8412813
[No Abstract] [Full Text] [Related]
20. Isolation and characterization of sulfhydryl and disulfide peptides of human apolipoprotein B-100.
Yang CY; Kim TW; Weng SA; Lee BR; Yang ML; Gotto AM
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5523-7. PubMed ID: 2115173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
